Episode 251 | Sarah Fox, Investor at Angelini Ventures | Navigating Venture Capital in MedTech

Episode notes

In this episode, Duane Mancini sits down with Sarah to unpack her path from healthcare operator to investor and what founders should know when raising capital today. Sarah shares how her experience as the 10th employee at a digital health startup shaped her empathy for founders and the practical lens she brings to diligence, from ICP and pricing to building durable foundations early. The conversation pulls back the curtain on venture mechanics - how syndication and relationships really work, why fundraising is difficult when LPs demand DPI, and how fund structure, lifecycle, and co-investments can shape outcomes for startups. Sarah also explains Angelini Ventures’ global strategy and thesis-driven focus in areas like cardiology and neurology, and why “exitability” requires forward-looking insight into strategic buyers, technology shifts, and long-term fit. Sarah Fox LinkedIn Angelini Ventures Website Duane Mancini LinkedIn Project Medtech Website Project Medtech LinkedIn Thank you to our sponsors: Ward Law and JumpStart Inc .

• Episode 266 | Laura Corcoran, CEO & Founder of Dignity Care | Innovating Compassionate Solutions for Pregnancy Loss56 / 100
• Episode 265 | Dr. Malcolm Townes, Innovation Fund Manager at Washington University | Strategic Medtech Commercialization: Lessons from the Gap Fund51 / 100
• Episode 264 | Will Kaigler & Megan Shaw | From Innovation to Impact: Crafting Medtech Culture and Success in Pittsburgh45 / 100
• Episode 263 | Mark Domyahn, Partner at JD Lymon Group | Strategic Reimbursement Planning for Medtech Innovators
• Episode 262 | Huzaifah Salat, MD, Physician Executive | Pioneering Lung Cancer Diagnosis & Driving Clinical Insight in Healthcare Innovation